News

The AI Journal
aijourn.com > venus-aerospace-strengthens-leadership-team-to-mature-rdre-propulsion-system-scale-operations

Venus Aerospace Strengthens Leadership Team to Mature RDRE Propulsion System, Scale Operations

3+ hour, 58+ min ago  (180+ words) Following its $91 million Series B, new and promoted leaders across government, product and operations build the capacity to carry RDRE from flight demonstration into a full propulsion system HOUSTON, July 16, 2026 /PRNewswire/ — Venus Aerospace today announced eight leadership additions, new hires…...

The AI Journal
aijourn.com > stryker-expands-mako-robotics-portfolio-with-full-market-release-of-mako-rps

Stryker expands Mako robotics portfolio with full market release of Mako RPS

5+ hour, 30+ min ago  (357+ words) New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic market PORTAGE, Mich., July 16, 2026 /PRNewswire/ — Stryker (NYSE: SYK), a global leader in medical technologies, announced today the U.S. commercial…...

The AI Journal
aijourn.com > immunobrain-announces-nature-medicine-publication-and-late-breaking-aaic-2026-presentation-for-ibc-ab002-in-early-alzheimers-disease

ImmunoBrain Announces Nature Medicine Publication and Late-Breaking AAIC 2026 Presentation for IBC-Ab002 in Early Alzheimer's Disease

2+ day, 10+ hour ago  (758+ words) The ultimate gateway for AI market insights, products, and solutions! The AI Journal provides news, analysis, opinions, and market trends specifically on emerging technologies to ambitious individuals and companies around the world. We equip businesses, governments, and educational institutes with…...

The AI Journal
aijourn.com > leqembi-subcutaneous-autoinjector-clinical-data-supports-similar-efficacy-and-safety-to-iv-formulation-in-early-alzheimers-disease-presented-at-the-alzheimers-association-international-confere

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference® (AAIC®) 2026

4+ day, 9+ hour ago  (319+ words) New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners AD is a chronic, progressive disease that requires ongoing treatment. LEQEMBI is an early AD treatment that…...

The AI Journal
aijourn.com > healthywomen-launches-brain-health-coalition-to-normalize-brain-health-as-part-of-midlife-care

HealthyWomen Launches Brain Health Coalition to Normalize Brain Health as Part of Midlife Care

6+ day, 6+ hour ago  (631+ words) The ultimate gateway for AI market insights, products, and solutions! The AI Journal provides news, analysis, opinions, and market trends specifically on emerging technologies to ambitious individuals and companies around the world. We equip businesses, governments, and educational institutes with…...

The AI Journal
aijourn.com > anthem-establishes-coverage-of-c2n-diagnostics-precivityad2-blood-test-for-alzheimers-disease-evaluation

Anthem Establishes Coverage of C2N Diagnostics’ PrecivityAD2® Blood Test for Alzheimer's Disease Evaluation

1+ week, 6+ hour ago  (187+ words) Medical policy marks a key commercial milestone as one of the nation’s largest insurers recognizes the clinical importance of Alzheimer’s blood biomarker testing By providing coverage for eligible patients, the policy helps reduce financial barriers to testing and expands access…...

The AI Journal
aijourn.com > pivot-point-consulting-appoints-terri-lefort-as-chief-executive-officer-to-lead-next-chapter-of-growth-and-innovation

Pivot Point Consulting Appoints Terri LeFort as Chief Executive Officer to Lead Next Chapter of Growth and Innovation

1+ week, 1+ day ago  (509+ words) PANAMA CITY, Fla., July 8, 2026 /PRNewswire/ — Pivot Point Consulting, a leading healthcare technology and services platform and the #1 Best in KLAS Managed IT Services firm, today announced the appointment of Terri LeFort as chief executive officer, effective July 8, 2026. LeFort brings more…...

The AI Journal
aijourn.com > zestyears-announces-inaugural-golden-grandparent-award-winners-elevating-grandparents-role-in-product-testing-and-family-purchasing

ZestYears Announces Inaugural Golden Grandparent Award Winners, Elevating Grandparents' Role in Product Testing and Family Purchasing

1+ week, 2+ day ago  (643+ words) As grandparents spend billions and take on larger caregiving roles, new national awards recognize the products they trust most while providing brands with direct consumer insight. ZestYears, a national grandparenting resource, created the Golden Grandparent Awards to help close that…...

The AI Journal
aijourn.com > hellonation-article-featuring-eye-care-experts-dr-i-paul-singh-and-dr-sanka-examines-why-doctors-recommend-early-glaucoma-treatment-racine-patients-can-benefit-from

HelloNation Article Featuring Eye Care Experts, Dr. I. Paul Singh and Dr. Sanka Examines Why Doctors Recommend Early Glaucoma Treatment. Racine Patients Can Benefit From

1+ week, 3+ day ago  (216+ words) The article explains how earlier intervention and newer procedures are changing decisions in glaucoma treatment and cataract care. RACINE, Wis., July 6, 2026 /PRNewswire/ — What is causing eye doctors to move away from the traditional “wait and see” approach for glaucoma and…...

Google News
aijourn.com > aureka-releases-opendde-an-open-source-drug-discovery-engine-designed-to-accelerate-ai-driven-therapeutic-discovery

Aureka Releases OpenDDE, an Open-Source Drug Discovery Engine Designed to Accelerate AI-Driven Therapeutic Discovery

1+ week, 2+ day ago  (117+ words) All-atom biomolecular foundation model uses co-folding as the entry point to a scalable drug discovery engine; the release marks a concrete step toward advancing open scientific AI for future biomedical research that benefit patients. LAGUNA HILLS, Calif. and SHANGHAI, July…...